![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ATP6AP1L |
Gene summary for ATP6AP1L |
![]() |
Gene information | Species | Human | Gene symbol | ATP6AP1L | Gene ID | 92270 |
Gene name | ATPase H+ transporting accessory protein 1 like (pseudogene) | |
Gene Alias | ATP6AP1L | |
Cytomap | 5q14.2 | |
Gene Type | pseudo | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
92270 | ATP6AP1L | HCC1 | Human | Liver | HCC | 2.26e-06 | 2.63e+00 | 0.5336 |
92270 | ATP6AP1L | HCC2 | Human | Liver | HCC | 2.90e-16 | 1.97e+00 | 0.5341 |
92270 | ATP6AP1L | HCC5 | Human | Liver | HCC | 6.15e-08 | 1.64e+00 | 0.4932 |
92270 | ATP6AP1L | PTC04 | Human | Thyroid | PTC | 1.15e-03 | 1.00e-01 | 0.1927 |
92270 | ATP6AP1L | PTC05 | Human | Thyroid | PTC | 8.07e-04 | 2.08e-01 | 0.2065 |
92270 | ATP6AP1L | PTC06 | Human | Thyroid | PTC | 1.58e-07 | 2.50e-01 | 0.2057 |
92270 | ATP6AP1L | PTC07 | Human | Thyroid | PTC | 1.21e-04 | 1.14e-01 | 0.2044 |
92270 | ATP6AP1L | ATC13 | Human | Thyroid | ATC | 5.43e-04 | 1.09e-01 | 0.34 |
92270 | ATP6AP1L | ATC2 | Human | Thyroid | ATC | 5.95e-07 | 7.87e-01 | 0.34 |
92270 | ATP6AP1L | ATC5 | Human | Thyroid | ATC | 2.74e-06 | 1.19e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Breast | Precancer | ![]() |
Breast | IDC | ![]() |
Breast | DCIS | ![]() |
Cervix | CC | ![]() |
Cervix | HSIL_HPV | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ATP6AP1L | SNV | Missense_Mutation | c.641T>C | p.Leu214Pro | p.L214P | Q52LC2 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-BH-A1FU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
ATP6AP1L | SNV | Missense_Mutation | rs550926078 | c.521G>A | p.Arg174Gln | p.R174Q | Q52LC2 | protein_coding | deleterious(0.03) | benign(0.05) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
ATP6AP1L | SNV | Missense_Mutation | c.589N>G | p.Thr197Ala | p.T197A | Q52LC2 | protein_coding | tolerated(1) | benign(0) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ATP6AP1L | SNV | Missense_Mutation | c.562N>T | p.His188Tyr | p.H188Y | Q52LC2 | protein_coding | tolerated(0.54) | benign(0.005) | TCGA-AA-3975-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ATP6AP1L | SNV | Missense_Mutation | c.160N>C | p.Ser54Pro | p.S54P | Q52LC2 | protein_coding | tolerated(0.1) | benign(0.027) | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ATP6AP1L | SNV | Missense_Mutation | c.664N>C | p.Ile222Leu | p.I222L | Q52LC2 | protein_coding | deleterious(0.03) | benign(0.003) | TCGA-A5-A0GP-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ATP6AP1L | SNV | Missense_Mutation | novel | c.184N>T | p.Arg62Cys | p.R62C | Q52LC2 | protein_coding | deleterious(0) | benign(0.34) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ATP6AP1L | SNV | Missense_Mutation | rs374101966 | c.277N>T | p.Arg93Cys | p.R93C | Q52LC2 | protein_coding | tolerated(0.12) | benign(0.001) | TCGA-AP-A05O-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
ATP6AP1L | SNV | Missense_Mutation | rs746756477 | c.569N>T | p.Ser190Leu | p.S190L | Q52LC2 | protein_coding | deleterious(0.03) | benign(0) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
ATP6AP1L | SNV | Missense_Mutation | rs774830030 | c.595N>A | p.Glu199Lys | p.E199K | Q52LC2 | protein_coding | tolerated(0.08) | benign(0.007) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |